Can a phone app help beat opioid addiction? new trial tests KIOS
NCT ID NCT06212557
First seen Apr 06, 2026 · Last updated Jun 21, 2026 · Updated 16 times
Summary
This study tests a mobile app called KIOS that gives personalized advice and support to people receiving medication-assisted treatment for opioid use disorder. Over 12 weeks, 116 participants will either use the app or receive standard counseling. The goal is to see if the app helps them stay in treatment longer and reduce opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Texas Health Science Center - Department of Psychiatry
San Antonio, Texas, 78229, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KIOS mobile app
What this could lead to
If successful, this app could provide an easy, on-demand tool to help people stick with their medication-assisted treatment and reduce opioid use.
What could go wrong
This is a relatively small, early-stage trial with 116 participants, so results may not apply to everyone. The app is an add-on to standard care, not a standalone treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.